From January 9, 2024 to March 31, 2024, the company has repurchased 2,946,800 shares, representing 1.9% for CNY 51.92 million. With this, the company has completed the repurchase of 2,946,800 shares, representing 1.9% for CNY 51.92 million under the buyback announced on January 9, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.22 CNY | -2.62% |
|
+2.19% | -28.35% |
1st Jan change | Capi. | |
---|---|---|
-28.35% | 381M | |
+63.05% | 856B | |
+39.42% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+14.19% | 244B | |
+5.81% | 234B | |
+16.77% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- 301201 Stock
- News ChengDa Pharmaceuticals Co., Ltd.
- Tranche Update on ChengDa Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on January 9, 2024.